The Global Health Body Raises Warning Over Severe Shortage of Weight-Loss Jabs

Less than a tenth of individuals who could benefit from obesity jabs like Wegovy can access them, caution the WHO as it releases its initial advice on the therapies.

With in excess of 1,000,000,000 individuals worldwide now living with obesity, it is calling for broader and more equitable availability to these injectable treatments.

Based on projections, over two billion are projected to be living with obesity by 2030 unless action is taken.

"Our new guidelines affirms that excess weight is a long-term condition that can be addressed with thorough and ongoing support," said its chief Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and distribution challenges are key barriers to broad availability to the jabs that can assist patients in reducing significant body mass, explains the organization.

Skinny Jab Supply Crisis

Even under the current most favorable case, the supply of these medications might only reach approximately 100 million people – less than 10% of those who need them, as stated by the WHO.

The recommendation encourages nations and manufacturers to widen access, through measures like licensing agreements.

Exclusive production rights on semaglutide – the main component of Novo Nordisk's Wegovy – is set to lapse in a number of countries in 2026.

The Way Weight-Loss Injections Operate

The injections replicate a body's own hormone to delay gastric emptying, curb appetite and enhance the sense of being full so people reduce food intake.

People typically begin shedding pounds within a few weeks of starting on the weekly injections.

Evidence indicates patients may regain a significant portion within a year of discontinuing the drug, when their usual appetite return.

To be carrying excess weight elevates your likelihood for contracting medical conditions, such as type 2 diabetes, cardiovascular issues, stroke, and certain cancers.

Obesity affects people in every country and was responsible for 3.7 million deaths worldwide in 2024, according to the WHO.

Susan Martin
Susan Martin

Evelyn is a seasoned journalist with over a decade of experience covering UK current affairs and digital innovation.